Potential 8 month base just starting it's move off the lower support line. Classic 4 point continuation pattern. Stochastics and MACD curling up.
Relief Therapeutics just held a conference call on concluding FDA Phase III trials for severe Covid using the drug Aviptadil (Zyesami). Expect filing for FDA EUA approval within a week and FDA approval in 30 days or less thereafter.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.